Histological assessment of SJL/J mice treated with the antioxidants coenzyme Q10 and resveratrol

Micron

Volumn 42, Issue 3, 2011, Pages 275-282

  Potgieter, M ^a   Pretorius, E ^a   Van der Merwe, C F ^b   Beukes, M ^b   Vieira, W A ^a   Auer, R E G ^b   Auer, M ^b   Meyer, S ^b  

^a UNIVERSITY OF PRETORIA   (South Africa)

^b UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

Antioxidant supplementation; Coenzyme Q10; Dysferlinopathy; Histopathology; Resveratrol

Indexed keywords

ANTIOXIDANT SUPPLEMENTATION; COENZYME Q10; DYSFERLINOPATHY; HISTOPATHOLOGY; RESVERATROL;

ANIMALS; DISEASES;

MUSCLE;

ANTIOXIDANT; DRUG DERIVATIVE; RESVERATROL; STILBENE DERIVATIVE; UBIDECARENONE; UBIQUINONE;

ANIMAL; ARTICLE; DISEASE MODEL; DRUG EFFECT; FEMALE; MOUSE; MUSCULAR DYSTROPHY; PATHOLOGY; SKELETAL MUSCLE;

ANIMALS; ANTIOXIDANTS; DISEASE MODELS, ANIMAL; FEMALE; MICE; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES; STILBENES; UBIQUINONE;

ANIMALIA; MUS;

EID: 78650755469     PISSN: 09684328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micron.2010.10.001     Document Type: Article

References (42)

1. Aragno M., Mastrocola R., Brignardello E., Catalano M., Robino G., Manti R., et al. Dehydroepiandrosterone modulates nuclear factor-κB activation in hippocampus of diabetic rats. Endocrinology 2002, 143(9):3250-3258.
2. Bansal D., Miyake K., Vogel S.S., Groh S., Chen C.C., Williamson R., et al. Defective membrane repair in dysferlin deficient muscular dystrophy. Nature 2003, 423:168-172.
3. Bansal D., Campbell K.P. Dysferlin and the plasma membrane repair in muscular dystrophy. Trends Cell Biol. 2004, 14(4):206-213.
4. Bentinger M., Brismar K., Dallner G. The antioxidant role of coenzyme Q. Mitochondrion 2007, 7(Suppl 1):S41-S50.
5. Bethlem J., van Wijngaarden G.K. The incidence of ringed fibers and sarcoplasmic masses in normal and diseased muscle. J. Neurol. Neurosurg. Psychiat. 1963, 26(4):326-332.
6. Bittner R.E., Anderson L.V.B., Burkhardt E., Bashir R., Vafiadaki E., Ivanova S., et al. Dysferlin deletion in SJL mice (SJLDysf) defines a natural model for limb girdle muscular dystrophy 2B. Nat. Genet. 1999, 23(2):141-142.
7. Briguet A., Courdier-Fruh I., Foster M., Meier T., Magyar J.P. Histological parameters for the quantitative assessment of muscular dystrophy in the mdx-mouse. Neuromuscul. Disord. 2004, 14(10):675-682.
8. Buck M., Chojkier M. Muscle wasting and dedifferentiation induced by oxidative stress in a murine model of cachexia is prevented by inhibitors of nitric oxide synthesis and antioxidants. EMBO J. 1996, 15(8):1753-1765.
9. Buetler T.M., Renard M., Offord E.A., Schneider H., Rüegg U.T. Green tea extract decreases muscle necrosis in mdx mice and protects against reactive oxygen species. Am. J. Clin. Nutr. 2002, 75(4):749-753.
10. Carpenter S., Karpati G. Pathology of Skeletal Muscle 1984, Churchill Livingston, New York.
11. Cenacchi G., Fanin M., De Giorgi L.B., Angelini C. Ultrastructural changes in dysferlinopathy support defective membrane repair mechanism. J. Clin. Pathol. 2005, 58:190-195.
12. Disatnik M.H., Dhawan J., Yu Y., Beal M.F., Whirl M.M., Franco A.A., et al. Evidence of oxidative stress in mdx mouse muscle: studies of the pre-necrotic state. J. Neurol. Sci. 1998, 161(1):77-84.
13. Fanin M., Angelini C. Muscle pathology in dysferlin deficiency. Neuropathol. Appl. Neurobiol. 2002, 28(6):461-470.
14. Frankel E.N., Kanner J., German J.B., Parks E., Kinsella J.E. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 1993, 341(8843):454-457.
15. Gallardo E., Rojas-García R., de Luna N., Pou A., Brown R.H., Illa I. Inflammation in dysferlin myopathy: immunohistochemical characterization of 13 patients. Neurology 2001, 57:2136-2138.
16. Grounds M.D., McGeachie J.K. A comparison of muscle precursor replication in crush-injured skeletal muscle of Swiss and BALBc mice. Cell Tissue Res. 1989, 255(2):385-391.
17. Grounds M.D., Torrisi J.O. Anti-TNFα (Remicade®) therapy protects dystrophic skeletal muscle from necrosis. FASEB J. 2004, 18(6):676-682.
18. Halliwell B., Gutteridge J.M.C. Free Radicals in Biology and Medicine 1989, Clarendon Press, Oxford. 2nd ed.
19. Ho M., Gallardo E., McKenna-Yasek D., De Luna N., Illa I., Brown R.H. A novel, blood-based diagnostic assay for limb girdle muscular dystrophy 2B and Miyoshi myopathy. Ann. Neurol. 2002, 51(1):129-133.
20. Hohlfeld R., Müller W., Toyka K.V. Necrotizing myopathy in SJL mice. Muscle Nerve 1988, 11(2):184-185.
21. Hu Y., Rahlfs S., Mersh-Sundermann V., Becker K. Resveratrol modulates mRNA transcripts of genes related to redox metabolism and cell proliferation in non-small-cell carcinoma cells. Biol. Chem. 2007, 388(2):207-219.
22. Jackson M.J., Jones D.A., Edwards R.H. Techniques for studying free radical damage in muscular dystrophy. Med. Biol. 1984, 62(2):135-138.
23. Kaczor J.J., Hall J.E., Payne E., Tarnopolsky M.A. Low intensity training decreases markers of oxidative stress in skeletal muscle of mdx mice. Free Radic. Biol. Med. 2007, 43:145-154.
24. Kar N.C., Pearson C.M. Catalase, superoxide dismutase, glutathione reductase and thiobarbituric acid-reactive products in normal and dystrophic human muscle. Clin. Chim. Acta 1979, 94(3):277-280.
25. Klinge L., Laval S., Keers S., Haldane F., Straub V., Barresi R., et al. From T-tubule to sarcolemma: damage-induced dysferlin translocation in early myogenesis. FASEB J. 2007, 21(8):1768-1776.
26. Kobayashi K., Izawa T., Kuwamura M., Yamate J. The distribution and characterization of skeletal muscle lesions in dysferlin-deficient SJL and A/J mice. Exp. Toxicol. Pathol. 2009, 62(5):509-517.
27. Linnane A.W., Kopsidas G., Zhang C., Yarovaya N., Kovalenko S., Papakostopoulos, et al. Cellular redox activity of coenzyme Q10: effect of CoQ10 supplementation on human skeletal muscle. Free Radic. Res. 2002, 36(4):445-453.
28. Mechler F., Imre S., Dioszeghy P. Lipid peroxidation and superoxide dismutase activity in muscle and erythrocytes in Duchenne muscular dystrophy. J. Neurol. Sci. 1984, 63(3):279-283.
29. Mitchell C.A., McGeachie J.K., Grounds M.D. Cellular differences in the regeneration of murine skeletal muscle: a quantitative histological study in SJL/J and Balb/c mice. Cell Tissue Res. 1992, 269(1):159-166.
30. Murphy M.E., Kehrer J.P. Oxidative stress and muscular dystrophy. Chem. Biol. Interact. 1989, 69(2-3):101-173.
31. Nemoto H., Konno S., Nakazora H., Miura H., Kurihara T. Histological and immunological changes of the skeletal muscles in older SJL/J mice. Eur. Neurol. 2007, 57(1):19-25.
32. Paradas C., González-Quereda L., De Luna N., Gallardo E., García-Consuegra I., Gómez H., et al. A new phenotype of dysferlinopathy with congenital onset. Neuromuscul. Disord. 2009, 19(1):21-25.
33. Prelle A., Sciacco M., Tancredi L., Fagiolari G., Comi C.P., Ciscato P., et al. Clinical, morphological and immunological evaluation of six patients with dysferlin deficiency. Acta Neuropathol. 2003, 105:537-542.
34. Ragusa R.J., Chow C.K., Porter J.D. Oxidative stress as a potential pathogenic mechanism in animal model of Duchenne muscular dystrophy. Neuromuscul. Disord. 1997, 7(6-7):379-380.
35. Robb E.L., Page M.M., Wiens B.E., Stuart J.A. Molecular mechanisms of oxidative stress resistance induced by resveratrol: specific and progressive induction of MnSOD. Biochem. Biophys. Res. Commun. 2008, 367(2):406-412.
36. Reagan-Shaw S., Nihal M., Ahmad N. Dose translation from animal to human studies revisited. FASEB J. 2008, 22(3):659-661.
37. Schotland D.L., Spiro D., Carmel P. Ultrastructural studies of ring fibers in human muscle disease. J. Neuropathol. Exp. Neurol. 1966, 25(3):431-442.
38. Selcen D., Stilling G., Engel A.G. The earliest pathological alterations in dysferlinopathy. Neurology 2001, 56:1472-1481.
39. Soleas G.J., Diamandis E.P., Goldberg D.M. Resveratrol: a molecule whose time has come? And gone?. Clin. Biochem. 1997, 30(2):91-113.
40. Suzuki N., Aoki M., Hinuma Y., Takahashi T., Onodera Y., Ishigaki A., et al. Expression profiling with progression of dystrophic change in dysferlin-deficient mice (SJL). Neurosci. Res. 2005, 52(1):47-60.
41. Weller A.H., Magliato S.A., Bell K.P., Rosenberg N.L. Spontaneous myopathy in the SJL/J mouse: pathology and strength loss. Muscle Nerve 1997, 20(1):72-82.
42. Zatz M., de Paula F., Starling A., Vainzof M. The 10 autosomal recessive limb-girdle muscular dystrophies. Neuromuscul. Disord. 2003, 13:532-544.